6,698
Views
19
CrossRef citations to date
0
Altmetric
Drug Profile

Clinical effectiveness and versatility of a sealing hemostatic patch (HEMOPATCH) in multiple surgical specialties

, , &
Pages 367-376 | Received 08 Mar 2018, Accepted 11 Apr 2018, Published online: 26 Apr 2018

References

  • Weiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015;385(Suppl 2):S11.
  • Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491–499.
  • Zegers M, de Bruijne MC, de Keizer B, et al. The incidence, root-causes, and outcomes of adverse events in surgical units: implication for potential prevention strategies. Patient Saf Surg. 2011;5:13.
  • Bracey A, Shander A, Aronson S, et al. The use of topical hemostatic agents in cardiothoracic surgery. Ann Thorac Surg. 2017;104:353–360.
  • Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 2011;11:135.
  • Govaert JA, Fiocco M, van Dijk WA, et al. Costs of complications after colorectal cancer surgery in the Netherlands: building the business case for hospitals. Eur J Surg Oncol. 2015;41:1059–1067.
  • Samudrala S. Topical hemostatic agents in surgery: a surgeon’s perspective. Aorn J. 2008;88:S2–S11.
  • Corral M, Ferko N, Hogan A, et al. A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding. Clinicoecon Outcomes Res. 2016;8:507–519.
  • Ikeme S, Weltert L, Lewis K, et al. Cost-effectiveness analysis of a sealing hemostat patch (HEMOPATCH) vs standard of care in cardiac surgery. J Med Econ. 2018;21(3):273-281.
  • Frantz VK, Lattes R. Oxidized cellulose-absorbable gauze (cellulosic acid). Jama. 1945;129(12):798–801.
  • Jenkins HP, Janda R, Clarke J. Clinical and experimental observations on the use of gelatin sponge or foam. Surgery. 1946;20(1):124–132.
  • Engvall E, Ruoslahti E, Miller E. Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med. 1978;147(6):1584–1595.
  • Winters KJ, Walsh J, Rubin B, et al. Platelet interactions with fibronectin: divalent cation-independent platelet adhesion to the gelatin-binding domain of fibronectin. Blood. 1993;81(7):1778–1786.
  • Xu J, Mosher D. Fibronectin and other adhesive glycoproteins. In: Mecham R, editor. The Extracellular Matrix: An Overview. Berlin, Springer Science & Business Media; 2011. pp. 41–75.
  • Miller J, Jackson D, Collier C. An investigation of the chemical reactions of oxidized regenerated cellulose. Exp Med Surg. 1961;19:196.
  • Hickerson WL, Nur I, Meidler R. A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants. Blood Coagul Fibrinolysis. 2011;22(1):19–23.
  • Gugerell A, Schossleitner K, Wolbank S, et al. High thrombin concentrations in fibrin sealants induce apoptosis in human keratinocytes. J Biomed Mater Res A. 2012;100(5):1239–1247.
  • Dhillon S. Fibrin sealant (evicel® [quixil®/crosseal™]): a review of its use as supportive treatment for haemostasis in surgery. Drugs. 2011;71(14):1893–1915.
  • Renkens KL Jr, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976). 2001;26(15):1645–1650.
  • Oz MC, Cosgrove DM 3rd, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg. 2000;69(5):1376–1382.
  • Fischer CP, Bochicchio G, Shen J, et al. A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery. J Am Coll Surg. 2013;217(3):385–393.
  • Öllinger R, Mihaljevic AL, Schuhmacher C, et al. A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery. Hpb. 2013;15(7):548–558.
  • Corral M, Ferko N, Hollmann S, et al. Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the premier perspectives database. Clinicoecon Outcomes Res. 2015;7:409–421.
  • Koea JB, Batiller J, Aguirre N, et al. A multicentre, prospective, randomized, controlled trial comparing EVARREST™ fibrin sealant patch to standard of care in controlling bleeding following elective hepatectomy: anatomic versus non-anatomic resection. HPB (Oxford). 2016;18(3):221–228.
  • Glineur D, Hendrikx M, Krievins D, et al. A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleeding. Med Devices (Auckl). 2018;8(11):65–75.
  • Howk K, Fortier J, Poston R. A novel hemostatic patch that stops bleeding in cardiovascular and peripheral vascular procedures. Ann Vasc Surg. 2016;31:186–195.
  • Schuhmacher C, Pratschke J, Weiss S, et al. Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleeding. Med Devices (Auckl). 2015;8:167–174.
  • Lewis KM, Spazierer D, Slezak P, et al. Swelling, sealing, and hemostatic ability of a novel biomaterial: a polyethylene glycol-coated collagen pad. J Biomater Appl. 2014;29:780–788.
  • Lewis KM, Kuntze CE, Gulle H. Control of bleeding in surgical procedures: critical appraisal of HEMOPATCH (Sealing Hemostat). Med Devices (Auckl). 2016;9:1–10.
  • Böhm S, Strauß C, Stoiber S, et al. Impact of source and manufacturing of collagen matrices on fibroblast cell growth and platelet aggregation. Materials. 2017;10(9):1086.
  • Lewis KM, McKee J, Schiviz A, et al. Randomized, controlled comparison of advanced hemostatic pads in hepatic surgical models. ISRN Surg. 2014;2014:930803.
  • Lewis KM, Schiviz A, Hedrich H-C, et al. Hemostatic efficacy of a novel, PEG-coated collagen pad in clinically relevant animal models. Int J Surg. 2014;12:940–944.
  • Baumgartner B, Draxler W, Lewis KM. Treatment of severe aortic bleeding using hemopatch in swine on dual antiplatelet therapy. J Invest Surg. 2016;29:343–351.
  • Lewis KM, Sweet J, Wilson ST, et al. Safety and efficacy of a novel, self-adhering dural substitute in a canine supratentorial durotomy model. Neurosurgery. 2018;82(3):397–406.
  • Imkamp F, Tolkach Y, Wolters M, et al. Initial experiences with the Hemopatch® as a hemostatic agent in zero-ischemia partial nephrectomy. World J Urol. 2015;33:1527–1534.
  • Fingerhut A, Uranues S, Ettorre G, et al. European initial hands-on experience with HEMOPATCH, a novel sealing hemostatic patch: application in general, gastrointestinal, biliopancreatic, cardiac, and urologic surgery. Surg Technol Int. 2014;25:29–35.
  • Jainandunsing JS, Al-Ansari S, Woltersom BD, et al. Novel hemostatic patch achieves sutureless epicardial wound closure during complex cardiac surgery, a case report. J Cardiothorac Surg. 2015;10:12.
  • Prestipino F, Nenna A, Casacalenda A, et al. Ventricular perforation by pacemaker lead repaired with two hemostatic devices. Int J Surg Case Rep. 2014;5:906–908.
  • Sandrio S, Purbojo A, Cesnjevar RA, et al. Hemopatch application for ventricular wall laceration in redo cardiac surgical procedures. Ann Thorac Surg. 2016;101:752–753.
  • Novotný R, LesensKy J, Hrubý J, et al. Chondrosarcoma resection followed by a branched crural revascularization of the right calf: case report. Cor Et Vasa. 2016;58:e470–e473.
  • U.S. Prevetative Services Task Force. Guide to clinical preventative services: report of the U.S. Preventative Services Task Force. [place unknown]: DIANE Publishing, 1989. Appendix A, Task Force Ratings; p.263.
  • Weltert L, D’Aleo S, Chirichilli I, et al. Prospective randomized clinical trial of HEMOPATCH topical sealant in cardiac surgery. Surg Technol Int. 2016; XXIX. pii: sti29/756. [Epub ahead of print].
  • Scheurer S, Schultz N, Storkholm J, et al. Comparison of two hemostatic agents (Hemopatch™ vs. TachoSil™) in liver resection, A clinical randomised trial. Hpb. 2016;18:e268.
  • Ruggiero R, Docimo L, Tolone S, et al. Effectiveness of an advanced hemostatic pad combined with harmonic scalpel in thyroid surgery, A prospective study. Int J Surg. 2016;28:S17–S21.
  • Serradilla M, Palomares A, Paterna S, et al. Sealing with NHS-PEG patch to prevent postoperative pancreatic fistula after pancreatojejunostomy. Poster presented at: 12th Biennial Congress of the European–African Hepato-Pancreato-Biliary Association; Mainz, Germany 2017.
  • Imkamp F, Von Klot C, Wolters M, et al. The role of Hemopatch® in zero ischemia laparoscopic partial nephrectomy. Eur Urol Supplements. 2016;15:e858.
  • Torres Melero J, Vargas Fernández M, Lorenzo L, et al. Use of the hemopatch resorbable collagen-based sealing hemostat to reinforce bowel anastomoses made in patients with peritoneal carcinomatosis treated with curative intent by complete cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). Poster presented at: XXXI Congreso Nacional de Cirugia Asociación Española de Cirgujanos; Madrid, Spain 2016.
  • González Pombo M, Rivero Garvia M, Rocha Romero S, et al. Dural reconstruction with heterologous plastia of collagen coated with NHS-PEG (pentaerythritol polyethylene glycol ether tetrasuccinimidyl glutarate). Lessons learned and experience in 200 cases. Oral presented at: XXI Congreso de la Sociedad Española de Neurocirugía; Barcelona, Spain 2017.
  • Tardáguila Serrano M, Gonçalves Ramírez FJ, Rimbau Muñoz J, et al. Use of hemostatic patterns as dural seals. Poster presented at: XXI Congreso de la Sociedad Española de Neurocirugía; Barcelona, Spain 2017.
  • Vuylsteke A, Pagel C, Gerrard C, et al. The papworth bleeding risk score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg. 2011;39:924–930.
  • Biancari F, Tauriainen T, Perrotti A, et al. Bleeding, transfusion and the risk of stroke after coronary surgery: A prospective cohort study of 2357 patients. Int J Surg. 2016;32:50–57.
  • Karthik S, Grayson AD, McCarron EE, et al. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg. 2004;78:527–534, discussion 534
  • Vivacqua A, Koch CG, Yousuf AM, et al. Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? Ann Thorac Surg. 2011;91:1780–1790.
  • Redžek A, Mironicki M, Gvozdenović A, et al. Predictors for hospital readmission after cardiac surgery. J Card Surg. 2015;30:1–6.
  • Murphy GJ, Angelini GD. Indications for blood transfusion in cardiac surgery. Ann Thorac Surg. 2006;82:2323–2334.
  • Ulrich F, Ettorre GM, Weltert L, et al. Intra-operative use of hemopatch®: interim results of a nationwide European survey of surgeons. Surg Technol Int. 2016;28:19–28.
  • ClinicalTrials.gov [Internet]. Identifier NCT02364791, A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures (Hemopatch) Bethesda (MD): National Library of Medicine (US); 2015 [updated 2017 Mar 29; cited 2017 Mar 29]. Available from: https://clinicaltrials.gov/show/NCT02364791
  • ClinicalTrials.gov [Internet]. Identifier NCT02633670, Hemopatch Versus No Hemopatch (Renal Transplant) Bethesda (MD): National Library of Medicine (US); 2015 [updated 2017 Oct 4; cited 2017 Oct 4]. Available from: https://clinicaltrials.gov/show/NCT02633670
  • ClinicalTrials.gov [Internet]. Identifier NCT02589483, Reinforcement of Rectal Anastomosis-RORA Bethesda (MD): National Library of Medicine (US); 2015 [updated 2017 Apr 13 cited 2017 Apr 13]. Available from: https://clinicaltrials.gov/show/NCT02589483
  • ClinicalTrials.gov [Internet]. Identifier NCT02491671, Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After Lung Resection Bethesda (MD): National Library of Medicine (US); 2015 [updated 2017 Oct 10; cited 2017 Oct 10]. Available from: https://clinicaltrials.gov/show/NCT02491671
  • ClinicalTrials.gov [Internet]. Identifier NCT02769754, Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection (HEMOPATCH) Bethesda (MD): National Library of Medicine (US); 2016 [updated 2016 Sep 7; cited 2016 Sep 7]. Available from: https://clinicaltrials.gov/show/NCT02769754
  • ClinicalTrials.gov [Internet]. Identifier NCT02777307, Demonstrate the Effectiveness to Hemopatch in Controlling Postoperative Bleeding After Laparoscopic Cholecistectomy and in Reducing of Morbidity and Postoperative Hospital Stay Bethesda (MD): National Library of Medicine (US); 2016 [updated 2016 May 19; cited 2016 May 19]. Available from: https://clinicaltrials.gov/show/NCT02777307
  • ClinicalTrials.gov [Internet]. Identifier NCT02668978, SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial Using HEMOPATCH Bethesda (MD): National Library of Medicine (US); 2016 [updated 2016 Feb 1; cited 2016 Feb 1]. Available from: https://clinicaltrials.gov/show/NCT02668978
  • ClinicalTrials.gov [Internet]. Identifier NCT03340090, Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery (Hemopatch) Bethesda (MD): National Library of Medicine (US); 2017 [updated 2017 Nov 14; cited 2017 Nov 14]. Available from: https://clinicaltrials.gov/show/NCT03340090
  • ClinicalTrials.gov [Internet]. Identifier NCT03323359, Efficacy and Tolerability of Hemopatch After Hepatic Resection Bethesda (MD): National Library of Medicine (US); 2017 [updated 2017 Nov 8; cited 2017 Nov 8]. Available from: https://clinicaltrials.gov/show/NCT03323359
  • ClinicalTrials.gov [Internet]. Identifier NCT03166683, Standard of Care Versus Hemopatch® During Liver Resection (IBERLIVER) Bethesda (MD): National Library of Medicine (US); 2017 [updated 2017 Nov 9; cited 2017 Nov 9]. Available from: https://clinicaltrials.gov/show/NCT03166683
  • Baratti D, Scivales A, Balestra MR, et al. Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol. 2010;36:463–469.
  • Daskalaki D, Butturini G, Molinari E, et al. A grading system can predict clinical and economic outcomes of pancreatic fistula after pancreaticoduodenectomy: results in 755 consecutive patients. Langenbecks Arch Surg. 2011;396:91–98.
  • Jamous N, Socievole G, Ferko N, et al. Economic analysis of evarrest(R) sealant matrix compared with standard of care in severe soft tissue surgical bleeding: an Italian hospital perspective. Value Health. 2015;18(7):A369.
  • Jamous N, Martini O, Ferko N, et al. Economic analysis of evarrest(R) sealant matrix compared with standard of care in severe soft tissue surgical bleeding: a German hospital perspective. Value Health. 2015;18(7):A369.
  • Jamous N, Carter S, Ferko N, et al. Economic analysis of evarrest(R) sealant matrix compared with standard of care in severe soft tissue surgical bleeding: a United Kingdom hospital perspective. Value Health. 2015;18(7):A368.
  • Martyn D, Kocharian R, Lim S, et al. Reduction in hospital costs and resource consumption associated with the use of advanced topical hemostats during inpatient procedures. J Med Econ. 2015;18:474–481.
  • Tackett SM, Calcaterra D, Magee G, et al. Real-world outcomes of hemostatic matrices in cardiac surgery. J Cardiothorac Vasc Anesth. 2014;28(6):1558–1565.
  • Price JS, Tackett S, Patel V. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery. J Med Econ. 2015;18(10):777–786.
  • Makhija D, Rock M, Ikeme S, et al. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients. J Med Econ. 2017;20:606–613.
  • Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944–982.
  • Goodnough LT, Shander A. Patient blood management. Anesthesiology. 2012;116(6):1367–1376.
  • American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management an updated report by the American society of anesthesiologists task force on perioperative blood management. Anesthesiology. 2015;122(2):241–275.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.